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Purpose
To evaluate the in vivo as well as in vitro anti-angiogen-
esis effects of melittin, a major polypeptide in bee
venom, and to elucidate its molecular mechanisms with
a special focus on VEGFR-2 mediated COX-2 and
MAPK pathways in VEGF-A-induced Lewis lung cancer
(VEGF-A-hm LLC) model and human lymphatic
endothelial cells (VEGF-A-HLECs).
Methods
We investigated the functional specificity of melittin as
an angiogenesis inhibitor using VEGF-A-induced in
vitro models and an in vivo lung metastasis mouse
model.
Results
Injection of 0.5mg/kg and 5mg/kg of melittin sup-
pressed tumor growth by 25.30% and 56.92%, respec-
tively; these results are superior to those obtained for
mice treated with the COX-2 inhibitor, NS398. Melittin
reduced tumor cell proliferation (PCNA), microvessel
density (MVD), expression of cyclooxygenase-2 (COX-
2), VEGF-A, and VEGFR-2, but did not affect VEGFR-1,
in VEGF-A-induced hm LLC tumors. Similarly, the
COX-2 inhibitor NS398 significantly inhibited prolifera-
tion, MVD, COX-2, VEGF-A, and VEGFR-2 expression
in the tumor section, supporting the role of COX-2 in
melittin-induced inhibition of angiogenesis. Melittin sig-
nificantly inhibited VEGF-A-induced proliferation and
tube formation in the endothelial cells. Melittin inhib-
ited phosphorylation of ERK 1/2, JNK and p38 MAPK
in a dose-dependent manner in VEGF-A-HLECs. p38
inhibitor SB203580 abolished the down regulation of
COX-2 and VEGF-A and anti-proliferative activity
induced by melittin.
Conclusion
These results suggest that melittin suppresses VEGF-A-
induced tumor growth and angiogenesis via VEGFR-2
mediated COX-2 and the MAPK-dependent pathway.
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